- Home
- ARMP vs AZ Comparison
ARMP vs AZ Comparison
Compare ARMP & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | AZ |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Canada |
| Employees | 61 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 318.1M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARMP | AZ |
|---|---|---|
| Price | $8.06 | $5.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | $15.00 |
| AVG Volume (30 Days) | 73.3K | ★ 554.4K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $532.60 |
| Revenue Next Year | N/A | $178.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.74 | $4.97 |
| 52 Week High | $14.98 | $12.36 |
Technical Indicators
Market Signals| Indicator | ARMP | AZ |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 40.10 |
| Support Level | $7.43 | $5.09 |
| Resistance Level | $12.11 | $6.93 |
| Average True Range (ATR) | 1.12 | 0.59 |
| MACD | -0.22 | -0.17 |
| Stochastic Oscillator | 14.20 | 38.65 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.